Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent
Prescription商品名： PNV-DHA
About This Medication
DESCRIPTION PNV-DHA + Docusate is a prescription prenatal/postnatal multivitamin/multimineral softgel with DHA. Each softgel is red in color and imprinted with “323” on one side. † Daily Value (DV) not established. SUPPLEMENT FACTS Serving Size: 1 softgel Amount Per Serving % Daily Value Vitamin C (as ascorbic acid, USP) 28 mg 47% Calcium (tribasic calcium phosphate, NF) 160 mg 16% Iron (as ferrous fumarate, USP) 27 mg 150% Vitamin D 3 (as cholecalciferol, USP) 400 IU 100% Vitamin E (as d-alpha-tocopherol acetate, USP) 30 IU 100% Vitamin B 6 (as pyridoxine HCl, USP) 25 mg 1250% Folic Acid, USP 1.25 mg 313% DHA (docosahexaenoic acid) 300 mg † Docusate sodium, USP 55 mg † OTHER INGREDIENTS Bovine Gelatin, Glycerin, Soybean Oil, Soy Lecithin, Purified Water, Yellow Beeswax, FD&C Red # 40, Titanium Dioxide, Orange Cream Flavor, Ethyl Vanillin, FD&C Yellow # 6, and FD&C Blue #1. Contains soy. INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
有効成分
| 成分 | 含有量 |
|---|---|
| .Alpha.-Tocopherol Acetate, Dl- | - |
| Ascorbic Acid | - |
| Calcium | - |
| Cholecalciferol | - |
| Doconexent | - |
| Ferrous Fumarate | - |
| Folic Acid | - |
| Pyridoxine | - |
適応症と用法
用量と投与方法
Side Effects Overview
警告と注意事項
WARNING Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
禁忌
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Frequently Asked Questions
INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.
DOSAGE AND ADMINISTRATION Usual adult dose is one (1) softgel daily or as directed by a physician. KEEP OUT OF REACH OF CHILDREN.
WARNING Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent drug label (National Library of Medicine)
- • openFDA — Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent label data (U.S. Food & Drug Administration)
- • NDC Directory — Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent (FDA National Drug Code)
医療免責事項
このページの情報は教育目的のみを意図しており、専門家による医療アドバイス、診断、または治療の代替として使用すべきではありません。
疾患や医薬品に関するご質問がある場合は、必ず担当医またはその他の資格を持つ医療専門家にご相談ください。
データソース： DailyMed (NLM), openFDA, MFDS